MONITORING DRUG SAFETY

被引：0
|
作者：
不详
机构：
来源：
LANCET | 1979年 / 1卷 / 8128期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1252 / 1252
页数：1
相关论文
共 50 条
  • [41] Identifying Safety Indicators of New Drug Safety Monitoring Programme (SMP) in Thailand
    Yaowalak Amrumpai
    Niyada Kiatying-Angsulee
    Kanittha Chamroonsawasdi
    Drug information journal : DIJ / Drug Information Association, 2007, 41 : 769 - 777
  • [42] DRUG SAFETY IN PSYCHIATRY - AN OBJECTIVE FOR DRUG-MONITORING IN PHASE-IV
    SCHMIDT, LG
    MULLEROERLINGHAUSEN, B
    PHARMACOPSYCHIATRY, 1984, 17 (05) : 152 - 156
  • [43] Early termination of drug trials - What are the ramifications for drug companies and drug safety monitoring boards?
    Jensen, Gorm Boje
    Hampton, John
    BRITISH MEDICAL JOURNAL, 2007, 334 (7589): : 326 - 326
  • [44] Drug Safety and the Cost of Monitoring: The Role of REMS in Risk Management
    Slomiany, Mark
    Bitar, Rema
    Kruse, Sarah
    Jeffers, Sarah
    Berkowitz, Kenneth
    Hassan, Mahmud
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (04) : 514 - 523
  • [45] Therapeutic drug monitoring assay development to improve efficacy and safety
    Pippenger, CE
    EPILEPSY RESEARCH, 2006, 68 (01) : 60 - 63
  • [46] Monitoring kidney safety in drug development: Emerging technologies and their implications
    Dieterle, Frank
    Marrer, Estelle
    Suzuki, Eiko
    Grenet, Olivier
    Cordier, Andre
    Vonderscher, Jacky
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (01) : 60 - 71
  • [47] Safety Monitoring of Herb-Drug Interactions A Component of Pharmacovigilance
    Skalli, Souad
    Soulaymani Bencheikh, Rachida
    DRUG SAFETY, 2012, 35 (10) : 785 - 791
  • [48] Monitoring drug safety:: A review of cefepime-induced neurotoxicity
    Abanades, S.
    Pardo, R.
    Rodríguez-Campello, A.
    Nolla, J.
    Farré, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 37 - 38
  • [49] Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter
    Clark C. Freifeld
    John S. Brownstein
    Christopher M. Menone
    Wenjie Bao
    Ross Filice
    Taha Kass-Hout
    Nabarun Dasgupta
    Drug Safety, 2014, 37 : 343 - 350
  • [50] FDA attempting to overcome major roadblocks in monitoring drug safety
    Zielinski, SL
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (12) : 872 - 873
12345